tiprankstipranks
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Income Statement

Compare
1,164 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q3 2024), Madrigal Pharmaceuticals's total revenue was $62.17M, an increase of Infinity% from the same quarter last year. In Q3, Madrigal Pharmaceuticals's net income was $-106.96M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -527.00K$ -467.00K$ -405.00K$ -471.00K$ -112.00K
Operating Expenses
$ 380.50M$ 293.57M$ 242.48M$ 206.67M$ 94.97M
Depreciation and Amortization
$ 527.00K$ 467.00K$ 405.00K$ 471.00K$ 112.00K
EBITDA
$ -379.97M$ -293.10M$ -242.08M$ -206.20M$ -94.86M
Operating Income
$ -380.50M$ -293.57M$ -242.48M$ -206.67M$ -94.97M
Other Income/Expenses
$ 6.87M$ -1.78M$ 636.00K$ 4.43M$ 11.02M
Pretax Income
$ -373.63M$ -295.35M$ -241.85M$ -202.24M$ -83.95M
Net Income
$ -373.63M$ -299.31M$ -241.08M$ -197.44M$ -72.81M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -19.99$ -17.47$ -14.58$ -12.78$ -4.73
Diluted EPS
$ -19.99$ -17.47$ -14.58$ -12.78$ -4.73
Weighted Average Shares Outstanding
18.69M 17.14M 16.54M 15.45M 15.39M
Weighted Average Shares Outstanding (Diluted)
18.69M 17.14M 16.54M 15.45M 15.39M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis